FERRARI, Silvia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.508
EU - Europa 3.310
AS - Asia 3.119
SA - Sud America 398
Continente sconosciuto - Info sul continente non disponibili 121
AF - Africa 64
OC - Oceania 5
Totale 17.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.341
GB - Regno Unito 1.588
SG - Singapore 911
CN - Cina 854
HK - Hong Kong 422
IT - Italia 330
BR - Brasile 307
SE - Svezia 262
FI - Finlandia 250
DE - Germania 248
VN - Vietnam 246
BD - Bangladesh 201
UA - Ucraina 189
TR - Turchia 175
FR - Francia 144
RU - Federazione Russa 122
CA - Canada 85
BG - Bulgaria 66
KR - Corea 49
ID - Indonesia 41
IN - India 39
AE - Emirati Arabi Uniti 34
AR - Argentina 32
MX - Messico 31
ZA - Sudafrica 29
NL - Olanda 25
EC - Ecuador 22
PK - Pakistan 21
JP - Giappone 20
IQ - Iraq 18
ES - Italia 15
PL - Polonia 15
CO - Colombia 13
IE - Irlanda 11
NP - Nepal 11
CL - Cile 10
BZ - Belize 9
MY - Malesia 9
UZ - Uzbekistan 9
VE - Venezuela 9
EG - Egitto 8
SA - Arabia Saudita 8
HN - Honduras 7
PH - Filippine 7
TT - Trinidad e Tobago 7
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
RO - Romania 6
TH - Thailandia 6
BY - Bielorussia 5
CH - Svizzera 5
MA - Marocco 5
AU - Australia 4
BE - Belgio 4
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
TW - Taiwan 4
AZ - Azerbaigian 3
ET - Etiopia 3
EU - Europa 3
LB - Libano 3
SN - Senegal 3
SV - El Salvador 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BB - Barbados 2
BS - Bahamas 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HT - Haiti 2
IR - Iran 2
KG - Kirghizistan 2
MN - Mongolia 2
OM - Oman 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GP - Guadalupe 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 17.400
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Ashburn 996
Fairfield 911
Santa Clara 828
Woodbridge 589
Singapore 580
Chicago 490
Hong Kong 417
Jacksonville 390
Houston 354
Seattle 343
Los Angeles 328
San Jose 313
Chandler 296
Cambridge 283
Wilmington 282
Council Bluffs 268
Dearborn 225
Ann Arbor 217
Salt Lake City 205
Hefei 194
Helsinki 190
Nyköping 184
Beijing 178
London 168
Izmir 113
New York 98
Tampa 94
Elk Grove Village 92
Ho Chi Minh City 80
The Dalles 75
Princeton 70
San Diego 65
Sofia 65
Bremen 62
Modena 61
Dallas 58
Eugene 58
Hanoi 58
Columbus 56
Lauterbourg 53
Sterling 50
Seoul 48
Buffalo 47
Lancaster 46
Milan 46
Boardman 43
Frankfurt am Main 37
Phoenix 37
São Paulo 37
Miami 34
Shanghai 34
Moscow 32
Dulles 29
Detroit 28
Jakarta 28
Atlanta 27
Des Moines 25
Toronto 24
Reading 20
Redwood City 17
Brooklyn 16
Da Nang 16
Kansas City 16
Rome 16
Mexico City 15
Tokyo 15
Dong Ket 14
Montreal 14
Warsaw 14
Kunming 13
Guangzhou 12
Haiphong 12
North Bergen 12
Norwalk 12
Orem 12
Chiswick 11
Curitiba 11
Dublin 11
Pittsburgh 11
Denver 10
Hangzhou 10
Hounslow 10
Jersey City 10
Saint Augustine 10
Belize City 9
Kilburn 9
Queens 9
Turin 9
Charlotte 8
Johannesburg 8
Lahore 8
Newark 8
San Francisco 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Delhi 7
Miano 7
Philadelphia 7
Totale 12.773
Salva come PNG Salva come JPEG
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 771
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 473
Endocrine manifestations of hepatitis C virus infection. 403
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 390
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 386
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 384
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 382
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 378
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 361
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 353
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 351
Cytokines and HCV-related disorders 351
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 348
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 347
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 340
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 339
Associations between Systemic Sclerosis and Thyroid Diseases 339
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 332
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 319
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 312
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 310
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 307
[CXCR3 and CXCL10 in autoimmune thyroiditis] 303
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 295
IP-10 in autoimmune thyroiditis 294
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 293
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 291
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 290
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 288
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 282
New targeted molecular therapies for dedifferentiated thyroid cancer 281
[Cryoglobulinemia and the α-chemokine IP-10] 271
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 271
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 271
Novel Therapies for Thyroid Autoimmune Diseases 264
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 259
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 258
RET TKI: potential role in thyroid cancers. 256
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 245
CXCL10 in psoriasis 243
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 234
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 234
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 232
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 232
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 224
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 222
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 218
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 215
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 214
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 212
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 209
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 206
Role of CXCL10 in cryoglobulinemia 190
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 180
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 178
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 175
HCV-related autoimmune disorders in HCV chronic infection. 170
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 167
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 164
Mixed cryoglobulinemia and thyroid autoimmune disorders 147
Hepatitis C virus infection and type 2 diabetes. 143
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 128
Totale 17.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022734 0 0 0 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20265.738 177 144 295 958 1.690 330 466 188 439 345 386 320
2026/20271.125 156 219 294 456 0 0 0 0 0 0 0 0
Totale 17.525